Triterpene Derivatives as Relevant Scaffold for New Antibiofilm Drugs
AbstractNew medicines for the treatment of bacterial biofilm formation are required. For this reason, this study shows the in vitro activity of betulinic acid (BA), ursolic acid (UA) and their twenty derivatives against planktonic and biofilm cells (gram-positive bacterial pathogens: Enterococcus faecalis, Staphylococcus aureus and Staphylococcus epidermidis). We evaluated the antibiofilm activity (through the crystal violet method), as well as the antibacterial activity via absorbance (OD600) at concentrations of 5, 25 and 100 µM. Likewise, the cytotoxicity of all compounds was evaluated on a kidney African green monkey (VERO) cell line at the same concentration, by MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) methodology. We verified for the first time whether different groups at carbon 3 (C-3) of triterpenes may interfere in the antibiofilm activity with minimal or no antibacterial effect. After the screening of 22 compounds at three distinct concentrations, we found antibiofilm activity for eight distinct derivatives without antibiotic effect. In particular, the derivative 2f, with an isopentanoyl ester at position C-3, was an antibiofilm activity against S. aureus without any effect upon mammalian cells. View Full-Text
Share & Cite This Article
da Silva, G.N.S.; Primon-Barros, M.; Macedo, A.J.; Gnoatto, S.C.B. Triterpene Derivatives as Relevant Scaffold for New Antibiofilm Drugs. Biomolecules 2019, 9, 58.
da Silva GNS, Primon-Barros M, Macedo AJ, Gnoatto SCB. Triterpene Derivatives as Relevant Scaffold for New Antibiofilm Drugs. Biomolecules. 2019; 9(2):58.Chicago/Turabian Style
da Silva, Gloria N.S.; Primon-Barros, Muriel; Macedo, Alexandre J.; Gnoatto, Simone C.B. 2019. "Triterpene Derivatives as Relevant Scaffold for New Antibiofilm Drugs." Biomolecules 9, no. 2: 58.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.